🔴 Cue Biopharma is trading 10.47% down today with no clear catalyst

Cue Biopharma is trading at $27.23 (-10.47%) after no verified company-specific announcement was identified for August 13, 2026.

• The latest official release, dated August 3, covered James M. Ahlers’ CFO appointment and the CUE-221 investigational new drug submission.
• The decline contrasts with broader market strength on August 13, 2026.
• No clear company, sector, or macro catalyst currently explains the drop.